GCOR Genencor International, (MM)

Genencor International to Present at the BIO CEO & Investor Conference PALO ALTO, Calif., Feb. 17 /PRNewswire-FirstCall/ -- Genencor International, Inc. (NASDAQ:GCOR) today announced that the company will present at the BIO CEO & Investor Conference at 2:00 p.m. EST on Wednesday, February 23, 2005 at the Waldorf Astoria Hotel in New York, New York. Jean-Jacques Bienaime, Genencor's chairman, chief executive officer and president will provide an overview of the company. The live audio webcast of the presentation as well as the replay will be available at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=GCOR&item_id=1009152 and the slide presentation may be accessed on the homepage at http://www.genencor.com/. About Genencor Genencor International is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable solutions to many of the problems of everyday life. Genencor traces its history to 1982 and has grown to become a leading biotechnology company, with over $410 million in year 2004 annual revenues. Genencor has principal offices in Palo Alto, California; Rochester, New York; and Leiden, the Netherlands. DATASOURCE: Genencor International, Inc. CONTACT: media, Valerie Tucker, +1-650-846-7571, or investors, Thomas Rathjen, +1-650-846-5810, both of Genencor International, Inc. Web site: http://www.genencor.com/

Copyright